Cennerv Pharma is a drug development company that is focused on bringing therapeutic small molecules for mental disorders or illnesses to market. We target diseases like depression, insomnia, dementia, attention-deficit hyperactivity disorder and Alzheimer’s diseases. The many advances of medical science has impacted very positively on the life span of the human being. However, with this extension of longevity, come also the problems of growing old. The world is facing an increasing global population and, in particular, a rapidly ageing population. Herein lies the tremendous opportunity for our products improving the quality of life years for humans and impacting on the dignity of those suffering from mental disorders.